Logo image of CVV

CVD EQUIPMENT CORP (CVV) Stock Fundamental Analysis

USA - NASDAQ:CVV - US1266011030 - Common Stock

4.1 USD
-0.09 (-2.15%)
Last: 10/22/2025, 8:24:22 PM
3.9664 USD
-0.13 (-3.26%)
After Hours: 10/22/2025, 8:24:22 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CVV. CVV was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. CVV scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CVV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CVV had negative earnings in the past year.
In the past year CVV has reported a negative cash flow from operations.
CVV had negative earnings in 4 of the past 5 years.
In the past 5 years CVV reported 4 times negative operating cash flow.
CVV Yearly Net Income VS EBIT VS OCF VS FCFCVV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M

1.2 Ratios

With a Return On Assets value of -1.22%, CVV perfoms like the industry average, outperforming 41.96% of the companies in the same industry.
CVV has a Return On Equity of -1.45%. This is comparable to the rest of the industry: CVV outperforms 45.54% of its industry peers.
Industry RankSector Rank
ROA -1.22%
ROE -1.45%
ROIC N/A
ROA(3y)-6.17%
ROA(5y)-3.99%
ROE(3y)-8.06%
ROE(5y)-6.61%
ROIC(3y)N/A
ROIC(5y)N/A
CVV Yearly ROA, ROE, ROICCVV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

CVV's Gross Margin of 26.28% is on the low side compared to the rest of the industry. CVV is outperformed by 75.89% of its industry peers.
CVV's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for CVV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.28%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.12%
GM growth 5Y10.58%
CVV Yearly Profit, Operating, Gross MarginsCVV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

5

2. Health

2.1 Basic Checks

CVV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CVV has been increased compared to 1 year ago.
CVV has more shares outstanding than it did 5 years ago.
CVV has a better debt/assets ratio than last year.
CVV Yearly Shares OutstandingCVV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
CVV Yearly Total Debt VS Total AssetsCVV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

CVV has an Altman-Z score of 4.67. This indicates that CVV is financially healthy and has little risk of bankruptcy at the moment.
CVV's Altman-Z score of 4.67 is in line compared to the rest of the industry. CVV outperforms 55.36% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that CVV is not too dependend on debt financing.
The Debt to Equity ratio of CVV (0.01) is better than 68.75% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 4.67
ROIC/WACCN/A
WACC11.54%
CVV Yearly LT Debt VS Equity VS FCFCVV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M

2.3 Liquidity

CVV has a Current Ratio of 4.00. This indicates that CVV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.00, CVV is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
A Quick Ratio of 3.49 indicates that CVV has no problem at all paying its short term obligations.
CVV has a better Quick ratio (3.49) than 66.96% of its industry peers.
Industry RankSector Rank
Current Ratio 4
Quick Ratio 3.49
CVV Yearly Current Assets VS Current LiabilitesCVV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

CVV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 93.51%, which is quite impressive.
The Revenue has grown by 34.37% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 6.46% on average over the past years.
EPS 1Y (TTM)93.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
Revenue 1Y (TTM)34.37%
Revenue growth 3Y17.78%
Revenue growth 5Y6.46%
Sales Q2Q%-19.53%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CVV Yearly Revenue VS EstimatesCVV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CVV Yearly EPS VS EstimatesCVV Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CVV. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CVV Price Earnings VS Forward Price EarningsCVV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CVV Per share dataCVV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CVV!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CVD EQUIPMENT CORP

NASDAQ:CVV (10/22/2025, 8:24:22 PM)

After market: 3.9664 -0.13 (-3.26%)

4.1

-0.09 (-2.15%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-12 2025-08-12/amc
Earnings (Next)11-11 2025-11-11
Inst Owners17.21%
Inst Owner Change0%
Ins Owners3.98%
Ins Owner Change2.22%
Market Cap28.21M
Revenue(TTM)29.04M
Net Income(TTM)-366000
Analysts0
Price TargetN/A
Short Float %0.91%
Short Ratio1.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.97
P/FCF N/A
P/OCF N/A
P/B 1.12
P/tB 1.12
EV/EBITDA N/A
EPS(TTM)-0.05
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.46
OCFYN/A
SpS4.22
BVpS3.66
TBVpS3.66
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.22%
ROE -1.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.28%
FCFM N/A
ROA(3y)-6.17%
ROA(5y)-3.99%
ROE(3y)-8.06%
ROE(5y)-6.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y15.12%
GM growth 5Y10.58%
F-Score5
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.69%
Cap/Sales 0.09%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4
Quick Ratio 3.49
Altman-Z 4.67
F-Score5
WACC11.54%
ROIC/WACCN/A
Cap/Depr(3y)63.48%
Cap/Depr(5y)67.31%
Cap/Sales(3y)2.07%
Cap/Sales(5y)3.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)34.37%
Revenue growth 3Y17.78%
Revenue growth 5Y6.46%
Sales Q2Q%-19.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y75.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-471.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-298.05%
OCF growth 3YN/A
OCF growth 5YN/A